Apixaban (Eliquis) -

Apixaban (Eliquis)
Information type: Drug best practice guidance
Source: Scottish Medicines Consortium
Specialities: Cardiovascular system disorders
Summary
The SMC has accepted apixaban (Eliquis) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults.
UKMi comment
In DRAFT guidance (March 2015) NICE has also recommended apixaban (Eliquis) as an option for treating and preventing venous thromboembolism (VTE) in adults.
Related links: Link to DRAFT NICE guidance